文献速递中毒与环境急症消化、代谢与肾脏急症

Communities That HEAL干预与死亡率包括多物质过量死亡:一项随机临床试验

Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial.
PubMed 文献 · JAMA Netw Open · 2024-10-01
一句话结论在67个高阿片过量死亡率社区中,CTH干预未显著降低总药物过量死亡率(aRR 0.92;95%CI 0.78-1.07;P=.26),但使阿片与非可卡因精神兴奋剂合并死亡降低37%(aRR 0.63;95%CI 0.44-0.91;P=.02)。

HEALing Communities Study(HCS)在2020至2023年间于美国4个州(肯塔基、马萨诸塞、纽约、俄亥俄)开展平行组、多站点、社区随机、开放、等待列表对照试验,纳入报告高阿片过量死亡率的67个社区(干预组34个、对照组33个),共8 211 506名成人。干预包括增加过量教育与纳洛酮分发、阿片使用障碍药物治疗、更安全的阿片处方实践以及沟通活动以减少污名并推动循证干预需求。主要结局为成人药物过量死亡数,2021年7月至2022年6月干预组每10万成人居民过量死亡率为57.6、对照组为61.2,差异无统计学意义(aRR 0.92;95%CI 0.78-1.07;P=.26);阿片与非可卡因精神兴奋剂合并死亡显著降低37%(aRR 0.63;95%CI 0.44-0.91;P=.02),阿片与可卡因合并死亡降低6%、阿片与苯二氮䓬合并死亡降低1%,均无统计学意义。作者认为,以社区为中心、数据驱动并扩大循证实践联合沟通活动的干预可能有效减少部分阿片相关多物质过量死亡。

要点

  • 在67个高阿片过量死亡率社区(干预组34个、对照组33个)中,CTH干预未显著降低总药物过量死亡率:干预组57.6/10万 vs 对照组61.2/10万(aRR 0.92;95%CI 0.78-1.07;P=.26)。
  • CTH干预使阿片与非可卡因精神兴奋剂合并过量死亡显著降低37%(aRR 0.63;95%CI 0.44-0.91;P=.02)。
  • 阿片与可卡因合并过量死亡降低6%、阿片与苯二氮䓬合并过量死亡降低1%,均无统计学意义。
  • 干预组成人居民4 251 903名女性(51.8%)、1 273 394名黑人(15.5%)、603 983名西班牙裔(7.4%)、5 979 602名白人(72.8%)、354 527名其他(4.3%)。

适用人群与场景

  • 美国肯塔基、马萨诸塞、纽约、俄亥俄4个州中报告高阿片过量死亡率的社区,随机分配为干预组34个社区、对照组33个社区,共8 211 506名成人(≥18岁)。
  • 试验为平行组、多站点、社区随机、开放、等待列表对照设计,2020至2023年开展,数据分析于2023年12月完成。

处置流程与药物剂量

  • 干预措施包括:增加过量教育与纳洛酮分发、阿片使用障碍药物治疗、更安全的阿片处方实践、以及旨在减少污名并推动循证干预需求的沟通活动。

红旗征与不能漏的情况

  • 阿片与非可卡因精神兴奋剂合并过量死亡是CTH干预显示显著降低(37%)的结局,需在社区层面识别并应对此类多物质过量。

研究设计与关键结果

  • 研究类型:平行组、多站点、社区随机、开放、等待列表对照试验;67个社区(干预组34个、对照组33个),8 211 506名成人;主要终点为2021年7月至2022年6月每10万成人居民药物过量死亡率。
  • 主要终点:干预组总药物过量死亡率为57.6/10万 vs 对照组61.2/10万,差异无统计学意义(aRR 0.92;95%CI 0.78-1.07;P=.26)。
  • 次要终点:阿片与非可卡因精神兴奋剂合并死亡降低37%(aRR 0.63;95%CI 0.44-0.91;P=.02);阿片与可卡因合并死亡降低6%、阿片与苯二氮䓬合并死亡降低1%,均无统计学意义。

证据类型、等级与局限

  • 证据类型:随机临床试验(社区随机、开放、等待列表对照)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,以社区为中心、数据驱动并扩大循证实践联合沟通活动的干预可能有效减少部分阿片相关多物质过量死亡;总药物过量死亡未显示统计学差异。

指南或共识出处

  • 试验注册:ClinicalTrials.gov Identifier: NCT04111939。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The HEALing Communities Study (HCS) evaluated the effectiveness of the Communities That HEAL (CTH) intervention in preventing fatal overdoses amidst the US opioid epidemic.

OBJECTIVE: To evaluate the impact of the CTH intervention on total drug overdose deaths and overdose deaths involving combinations of opioids with psychostimulants or benzodiazepines.

DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was a parallel-arm, multisite, community-randomized, open, and waitlisted controlled comparison trial of communities in 4 US states between 2020 and 2023. Eligible communities were those reporting high opioid overdose fatality rates in Kentucky, Massachusetts, New York, and Ohio. Covariate constrained randomization stratified by state allocated communities to the intervention or control group. Trial groups were balanced by urban or rural classification, 2016-2017 fatal opioid overdose rate, and community population. Data analysis was completed by December 2023.

INTERVENTION: Increased overdose education and naloxone distribution, treatment with medications for opioid use disorder, safer opioid prescribing practices, and communication campaigns to mitigate stigma and drive demand for evidence-based interventions.

MAIN OUTCOMES AND MEASURES: The primary outcome was the number of drug overdose deaths among adults (aged 18 years or older), with secondary outcomes of overdose deaths involving specific opioid-involved drug combinations from death certificates. Rates of overdose deaths per 100 000 adult community residents in intervention and control communities from July 2021 to June 2022 were compared with analyses performed in 2023.

RESULTS: In 67 participating communities (34 in the intervention group, 33 in the control group) and including 8 211 506 participants (4 251 903 female [51.8%]; 1 273 394 Black [15.5%], 603 983 Hispanic [7.4%], 5 979 602 White [72.8%], 354 527 other [4.3%]), the average rate of overdose deaths involving all substances was 57.6 per 100 000 population in the intervention group and 61.2 per 100 000 population in the control group. This was not a statistically significant difference (adjusted rate ratio [aRR], 0.92; 95% CI, 0.78-1.07; P = .26). There was a statistically significant 37% reduction (aRR, 0.63; 95% CI, 0.44-0.91; P = .02) in death rates involving an opioid and psychostimulants (other than cocaine), and nonsignificant reductions in overdose deaths for an opioid with cocaine (6%) and an opioid with benzodiazepine (1%).

CONCLUSION AND RELEVANCE: In this clinical trial of the CTH intervention, death rates involving an opioid and noncocaine psychostimulant were reduced; total deaths did not differ statistically. Community-focused data-driven interventions that scale up evidence-based practices with communications campaigns may effectively reduce some opioid-involved polysubstance overdose deaths.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04111939.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Freisthler B, Chahine RA, Villani J, et al. Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial. JAMA Netw Open. 2024. PMID: 39432308. doi:10.1001/jamanetworkopen.2024.40006

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。